Firalis
PrivateLast Round
Grant
Nov 26, 2024
Total Funding Raised
$1.37M
Company Overview
Firalis is a biotechnology company that specializes in biomarker discovery, development, and regulatory qualification for diagnostic, prognostic, and theranostic applications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service, Hardware Sales
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Firalis Comparables
Compare Firalis with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Acobiom | 87% | |
| Fios Genomics | 83% | |
| CellCarta | 80% |
Firalis Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 26, 2024 | ||||
| Grant | Dec 12, 2023 | ||||
| Convertible Debt | Jan 29, 2019 | ||||
| VC Round | Jul 1, 2013 | ||||
| Seed | Dec 2, 2010 |
Key People
Founding team and executive leadership
Firalis Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Auriga Partners | VC Round |
| Capital Grand Est | VC Round, Seed |
| SODIV | VC Round, Seed |
| Bpifrance | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 1, 2026
Monthly visitors grew 1457% MoM, from 61 to 950.
- Feb 3, 2026
Grew 35% QoQ, from 23 to 31 employees.
Firalis Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Firalis's valuation, stock price, and market status.
Is Firalis a public or private company?
Firalis is a private company.
What is the current stock price of Firalis?
Firalis is a private company with no public stock price. Caplight tracks Firalis's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Firalis worth (valuation)?
Valuation information for Firalis is not publicly available.
Can I buy Firalis stock?
Firalis shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Firalis's last funding round?
Firalis's most recent funding round was Grant on November 26, 2024.
Who are the main investors in Firalis?
Key investors in Firalis include Auriga Partners, Capital Grand Est, SODIV, Bpifrance.
Will Firalis IPO soon?
No public IPO plans have been announced for Firalis.
How can I track Firalis secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Firalis's secondary market activity and sign up for updates.